title: Eculizumab for atypical hemolytic-uremic syndrome.
authors.forename: Jens
authors.initials: J
authors.lastname: Nürnberger
authors.forename: Thomas
authors.initials: T
authors.lastname: Philipp
authors.forename: Oliver
authors.initials: O
authors.lastname: Witzke
authors.forename: Anabelle
authors.initials: A
authors.lastname: Opazo Saez
authors.forename: Udo
authors.initials: U
authors.lastname: Vester
authors.forename: Hideo Andreas
authors.initials: HA
authors.lastname: Baba
authors.forename: Andreas
authors.initials: A
authors.lastname: Kribben
authors.forename: Lothar Bernd
authors.initials: LB
authors.lastname: Zimmerhackl
authors.forename: Andreas R
authors.initials: AR
authors.lastname: Janecke
authors.forename: Mato
authors.initials: M
authors.lastname: Nagel
authors.forename: Michael
authors.initials: M
authors.lastname: Kirschfink
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003180:Complement C3b Inactivator Proteins / Q000235:genetics; D003182:Complement C5 / Q000037:antagonists & inhibitors*; D017242:Complement Factor H / Q000235:genetics*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007668:Kidney / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery; D016030:Kidney Transplantation; D020125:Mutation, Missense; D012008:Recurrence; D017384:Sequence Deletion
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C517621:CFHR1 protein, human; D003180:Complement C3b Inactivator Proteins; D003182:Complement C5; D007155:Immunologic Factors; D017242:Complement Factor H; C481642:eculizumab